Table 1.
All cases | Trx-1 protein | |||
---|---|---|---|---|
(n = 144) | High expression | Low expression | P value | |
Sex | P = 0.107 | |||
Male | 45 | 16 | 29 | |
Female | 99 | 50 | 49 | |
Age (years) | P = 0.871 | |||
<65 | 95 | 44 | 51 | |
≥65 | 49 | 22 | 27 | |
Clinical stage | P = 0.029∗ | |||
I–II | 79 | 43 | 36 | |
III–IV | 65 | 23 | 42 | |
Differentiation grade | P = 0.080‡ | |||
Well | 1 | 0 | 1 | |
Moderate | 58 | 22 | 36 | |
Poor | 81 | 42 | 39 | |
Missing | 4 | 2 | 2 | |
Tumor stage | P = 0.003∗,‡ | |||
N0/Ia | 59 | 34 | 25 | |
N1/Ib | 26 | 14 | 12 | |
N2/IIa | 24 | 8 | 16 | |
N3/IIb | 35 | 10 | 25 | |
Tumor size (cm) | P < 0.001∗ | |||
<3.4 | 66 | 41 | 25 | |
≥3.4 | 78 | 25 | 53 |
∗χ2 test or Fisher's exact test. ‡Mann-Whitney U test (nonparametric). All missing values were excluded during statistical analyses. ∗ P < 0.05, which was considered statistically significant.